What is the Link Between Gut Microbiome and Lynch Syndrome Cancer?
‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever (News)
‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever Pain News Network 15 November 2022 https://www.painnewsnetwork.org/stories/2022/11/15/promising-results-for-low-dose-naltrexone-as-pain-reliever Low-dose naltrexone (LDN) continues to get more recognition from the medical community as a treatment for some types of chronic pain. In smaller doses of 5mg or less, patients with fibromyalgia, interstitial cystitis, intractable pain and other chronic conditions have […]
Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions (News)
Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions Medical Dialogues 15 November 2022 https://medicaldialogues.in/medicine/news/low-dose-naltrexone-promising-for-pain-relief-in-fibromyalgia-and-host-of-chronic-conditions-102374 A new study found that low dose naltrexone (LDN) helped with chronic pain stemming from various conditions including fibromyalgia, Crohn’s disease, diabetic neuropathy, axial low back pain, rheumatoid arthritis, and complex regional pain syndrome. A review […]
The LDN Book 3 (LDN; low dose naltrexone)
The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details
Kara – United States: Multiple Sclerosis (MS) (LDN; low dose naltrexone)
Linda Elsegood: Welcome to the LDN radio show brought to you by the LDN Research Trust I’m your host, Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low-dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for […]
Dosing of Low Dose Naltrexone (LDN)
Sleep Issues and Low Dose Naltrexone (LDN)
The Immune System and Low Dose Naltrexone (LDN)
LDN Webinar 18 May 2022 (LDN; low dose naltrexone)
LDN Webinar 18 May 2022 (LDN; low dose naltrexone) LDN Questions Answered Live by Pharmacist Dr Masoud Rashidi – LDN Specialist Dr Sato-Re Dr Mathewson Sponsored by Innovative Compounding Pharmacy icpfolsom.com
Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease… (Abstract)
Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study BMJ Open 08 April 2022 https://pubmed.ncbi.nlm.nih.gov/35396307/ Introduction: Crohn’s disease (CD) is an inflammatory bowel disease (IBD). Several drugs exist to induce and maintain remission, but a significant part of the […]